Alternatives to CytoReason

Mapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery.

Data-driven drug discovery and development company using machine learning and high-throughput biology.

AI-powered platform for predicting drug efficacy and safety, reducing clinical trial failures.

Digital therapeutics platform enhancing drug efficacy and safety through personalized software.

Precision oncology company developing cancer therapies guided by proprietary functional genomics.

Biotech company using AI and deep RNA analysis to predict cancer treatment response.

Developing a liquid biopsy blood test for early disease detection and monitoring using epigenetic information.

Developing novel diagnostics to predict patient response to immunotherapy.

Develops AI-powered decision support tools for personalized medical data interpretation and prediction.

Integrates scientific big data with patient medical records for personalized disease models and AI-driven insights.

Transforming healthcare by turning scientific fiction into scientific facts.

Microbiome technology platform for developing novel therapeutics.

AI-powered multi-omics platform for early breast cancer detection and risk prediction.

AI-powered IVF clinic solutions for digitization and automation.

AI-powered spatial biology platform for precision medicine and drug development.

Genoox provides a cloud-based AI platform for genomic data analysis, connecting clinicians and healthcare organizations.

Ukko is developing novel food allergy and disorder treatments using advanced immunology and plant science.

AI-powered personalized screening for early disease detection using non-invasive methods.

Developing genetic medicines and cell therapies for severe diseases using proprietary CRISPR OMNI technology.

AI-powered platform connecting cancer patients to advanced treatments and clinical trials.

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

AI-powered platform for autonomous, point-of-care interpretation of fundus images for diabetic retinopathy.

Harnessing genetic data for digital insights in rare and germline disorders.

AI platform for accelerating novel peptide therapeutic discovery and development.

Developing AI-driven solutions for optimizing chronic condition treatment efficacy and tolerance.

Develops human antibodies targeting functional epitopes for challenging therapeutic areas using AI-driven computational design.

Leveraging proteomic pattern analysis to personalize cancer treatment and improve patient outcomes.

Scent-based multi-cancer early detection screening test using AI and bio-detectors.

BiotaX leverages an AI-powered microbial ecology platform to discover and engineer natural microbial communities for health, food, and climate applications.

Biotechnology company developing inhaled therapies for genetic diseases, focusing on Cystic Fibrosis.

AI-driven platform for faster and more efficient diagnosis of women's health issues.

AI-powered medical technology revolutionizing sleep apnea diagnosis and treatment.

Biotechnology company personalizing medical cannabis treatment using metabolic biomarker analysis.

AI-powered platform for early detection and treatment selection of autoimmune diseases.

A global oncology company developing and commercializing innovative cancer treatments.

AI-powered solutions for revolutionizing male fertility diagnostics and treatment.

Developing human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.

AI-powered platform to predict and prevent adverse drug reactions, reducing hospitalizations.

AI-powered CT-based prediction model for simulating human bone response to load.

Caris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling.

Biopharmaceutical company developing novel small-molecule therapeutics for rare kidney diseases, particularly Autosomal Dominant Polycystic Kidney Disease (ADPKD).

A biotechnology company developing gene therapy treatments for rare, debilitating genetic diseases.

AI-powered patient-centric drug simulations to accelerate and de-risk drug development.

Guardant Health is a precision oncology company that develops and commercializes liquid biopsy tests for cancer detection, recurrence monitoring, and treatment selection.

AI-driven platform for protein-level disease mapping and drug discovery.

Biomedical platform with intelligent search for medical citations and clinical trial recruitment.

Personalized medicine startup focused on accurate cancer treatment through advanced diagnostics and functional drug sensitivity testing.

Developing oral small molecule medicines for immunological and chronic diseases.

A precision biotechnology company developing a blood-based platform for early cancer detection and treatment.

Revolutionizing drug design using quantum computing, AI, and personalized medicine.

A clinical-stage biopharmaceutical company developing novel cell therapies for AL Amyloidosis and other serious diseases.

BioCorteX is a tech bio company developing precision medicine solutions using AI-powered in-silico simulations to understand drug-bacteria interactions and personalize treatments.

High-resolution T-cell receptor repertoire analysis for immunological insights and therapeutic development.

A biopharmaceutical company developing RNA interference (RNAi)-based medicines.

AI platform for discovering complex multi-omics signatures for personalized medicine.

Cloud-based platform for reproducible computational research in life sciences.